Positron Emission Tomography using 64Cu-SAR-bisPSMA in participants with high-risk prostate cancer prior to radical prostatectomy: A prospective, single-arm, multi-center, blinded-review, Phase 3 diagnostic performance study
Clinical Trial Grant
Administered By
Radiology, Nuclear Medicine
Awarded By
Clarity Pharmaceuticals Pty Ltd (Clarity Pharmaceuticals)
Start Date
August 27, 2024
End Date
September 30, 2027
Administered By
Radiology, Nuclear Medicine
Awarded By
Clarity Pharmaceuticals Pty Ltd (Clarity Pharmaceuticals)
Start Date
August 27, 2024
End Date
September 30, 2027